The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSUBX.L Regulatory News (SUBX)

  • There is currently no data for SUBX

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Outcome of the Board Meeting held on August 8,2022

9 Aug 2022 10:35

RNS Number : 4239V
Subex Limited
09 August 2022
 

August 09, 2022

 

To

The London Stock Exchange

10 Paternoster Square

London

EC4M 7LS

 

Dear Sir/Madam,

 

Sub: Subex Limited "The Company"-Outcome of the Board Meeting held on August 08, 2022

 

Please be informed that the agenda items summarized hereunder were discussed and approved at the Board Meeting held on August 08, 2022 at Bengaluru:

 

1. Approval of the Unaudited Consolidated Financial Results of the Company for the quarter ended June 30, 2022.

 

2. The 28th Annual General Meeting (AGM) of the members of the Company is scheduled to be held on Monday, September 19, 2022, through Video Conference/ Other Audio Visual Means (VC/OAVM). The Register of Members and Share Transfer Books will remain closed from September 13, 2022 to September 19, 2022 (inclusive of both days), for administrative reasons pertaining to the AGM.

 

Please find enclosed:

 

· The Un-audited Consolidated Financial Results of the Company for the quarter ended June 30, 2022.

 

We request you to take on record the aforesaid information.

 

Thanking you

 

Yours truly,

For Subex Limited

Sd/-

Vinod Kumar Padmanabhan

Managing Director & CEO

DIN:06563872

 

 

 

 

 

 

 

 

SUBEX LIMITED

Registered office: Pritech Park - SEZ, Block-09, 4th Floor, B Wing, Survey No. 51-64/4, Outer ring road, Bellandur Village,Varthur Hobli, Bangalore -560 103

Statement of Consolidated Financial Results for quarter ended June 30, 2022

( in Lakhs)

Quarter ended

Year ended

Particulars

June 30, 2022

March 31, 2022

June 30, 2021

March 31, 2022

Unaudited

Audited

Unaudited

Audited

(Refer note 10)

1

Revenue from operations

8,326

7,880

8,060

33,344

2

Other income

265

200

671

1,037

3

Total income (1+2)

8,591

8,080

8,731

34,381

Expenses

Employee benefits expense (Refer note 4)

5,156

5,412

5,107

21,449

Finance costs

28

32

41

194

Depreciation and amortization expense

261

248

242

988

Other expenses (Refer note 6)

3,099

2,367

1,333

8,381

4

Total expenses

8,544

8,059

6,723

31,012

5

Net profit before tax (3-4)

47

21

2,008

3,369

6

Tax expense, net

Current tax charge/ (reversal) MAT credit entitlement

Provision - foreign withholding taxes (Refer note 5) Deferred tax (credit)/ charge (Refer note 9)

121

(165)

92

251

(109)

(25)

(23)

(141)

135

85

65

593

(654)

65

526

567

Total tax expense

(507)

(40)

660

1,270

7

Net profit for the period/ year (5-6)

554

61

1,348

2,099

8

Other comprehensive income/ (loss) net of tax expense

Items that will be reclassified subsequently to profit or loss:

Net exchange differences gain on translation of foreign operations

Items that will not be reclassified subsequently to profit or loss:

Re-measurement (loss)/ gain on defined benefit plan

300

204

150

267

 

(16)

 

41

 

(3)

 

(64)

Total other comprehensive income/ (loss)

284

245

147

203

9

Total comprehensive income for the period/ year (7+8)

838

306

1,495

2,302

10

Paid up equity share capital

28,100

28,100

28,100

28,100

[face value of ₹ 5 (March 31, 2022: ₹ 5)]

11

Other equity

-

-

-

28,267

12

Earnings per share (of ₹ 5/- each) (not annualised in case of the interim periods)

- Basic

0.10

0.01

0.25

0.38

- Diluted

0.10

0.01

0.24

0.38

 

 

1

Notes:

The above results have been reviewed by the Audit Committee and approved by the Board of Directors in their meeting held on August 8, 2022.

The financial results have been prepared in accordance with the recognition and measurement principles laid down in the applicable Indian Accounting Standards ("Ind AS") prescribed under section 133 of the Companies Act, 2013, read with relevant rules thereunder and in terms of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended.

The financial results of Subex Limited (Standalone information):

( in Lakhs)

2

 

3

Quarter ended

Year ended

 

Particulars

June 30, 2022

March 31, 2022

June 30, 2021

March 31, 2022

Unaudited

Audited (Refer note 10)

Unaudited

Audited

Total income

Net (loss)/ profit before tax

Net profit/ (loss) for the period/ year

Total comprehensive income/ (loss) for the period/ year

7,984

(1,107)

46

45

1,632

(674)

(674)

(652)

1,700

269

269

269

6,842

(447)

(447)

(450)

4

Employee benefits expenses for the quarter ended June 30, 2022, March 31, 2022, June 30, 2021 and for the year ended March 31, 2022 are net of reversal of provision no longer required in respect of employee incentives amounting to ₹ 185 Lakhs, ₹ 161 Lakhs, ₹ 786 Lakhs and ₹ 786 Lakhs respectively.

5

Represents reversal/provision in respect of foreign withholding taxes deducted/ deductible by the overseas customers of the Group.

6

During the quarter ended June 30, 2022, an amount of ₹ 866 Lakhs was provided on a conservative basis as doubtful debts towards receivable from one of the customer. Notwithstanding the provision, the management is confident to recover the aforesaid amount.

7

The Group is engaged in the business of software products and related services, which are monitored as a single segment by the Chief Operating Decision Maker, accordingly, these, in the context of Ind AS 108 on Operating Segments Reporting are considered to constitute one segment and hence the Group has not made any additional segment disclosures.

8

The US Federal government in the wake of COVID 19 pandemic provided support to business through Paycheck Protection Program (PPP). Subex Inc. obtained a benefit under this scheme for

₹600 Lakhs during May 2020. During the quarter ended June 30, 2021 and previous year ended March 31, 2022, Subex Inc. obtained complete waiver of the loan amount from Small Business Administration, United States government agency and accordingly the loan and interest accrued thereon was recognised as other income.

9

Pursuant to approval of the Board of Directors and Shareholders of the Company for restructuring of the business, effective April 1, 2022, business carried out by Subex Assurance LLP, wholly owned subsidiary, is transferred to the Company on a 'going concern' basis excluding Developed Technology & related research and development unit and Investment in subsidiaries for an aggregate consideration of ₹ 9,229 Lakhs. The aforesaid restructuring is being carried out to achieve higher operational efficiencies upon integration and consolidation of business in the listed entity. Consequent to the aforesaid restructuring, management has recognised deferred tax assets of ₹ 702 Lakhs, being reasonably certain that sufficient future taxable profits would be available to utilise these deferred tax assets. In respect of remaining unused tax losses, management would reassess and recognise when its probable that taxable profits would be available against which such tax losses can be recognised.

10

The figures of last quarter of previous year are the balancing figures between the audited figures in respect of the full financial year ended March 31, 2022 and the published unaudited year to date figures for the nine months ended December 31, 2021.

 

 

 

Place: Bengaluru

Date: August 8, 2022

 

 

 

 

 

For further details on the results, please visit our website: www.subex.com

 

 

 

Vinod Kumar Padmanabhan Managing Director & CEO

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCSSSSUUEESEDA
Date   Source Headline
9th Aug 202210:35 amRNSOutcome of the Board Meeting held on August 8,2022
30th Jun 20223:42 pmRNSProposed termination of GDRs & De-listing
1st Jun 202211:52 amRNSOutcome of Board Meeting dated May 30, 2022
1st Feb 202211:11 amRNSOutcome of Board Meeting held on Jan 31, 2022
29th Oct 20218:37 amRNSOutcome of Board Meeting held on October 28, 2021
10th Aug 202111:41 amRNSOutcome of the Board Meeting on August 09, 2021
15th Jun 202111:56 amRNSNotice of Twenty Seventh Annual General Meeting
18th May 202111:20 amRNSOutcome of the Board Meeting held on May 17, 2021
2nd Feb 202112:38 pmRNSOutcome of the Board Meeting February 01,2021
10th Nov 202011:32 amRNSOutcome of the Board Meeting November 09,2020
1st Sep 202012:01 pmRNSNotice of the Twenty Sixth Annual General Meeting
11th Aug 20202:34 pmRNSOutcome of Board Meeting on August 10, 2020
12th May 20207:31 amRNSSubex Limited-Outcome of Board Meeting 11 May 2020
12th Feb 20207:00 amRNSOutcome of the Board Meeting of Subex Limited
11th Nov 201910:17 amRNSResults for quarter & half year ended Sep 30, 2019
13th Aug 201911:02 amRNSOutcome of the Board Meeting - August 12, 2019
10th Jun 201911:55 amRNSNotice of the Twenty Fifth Annual General Meeting
14th May 20199:51 amRNSSubex Limited Outcome -Board Meeting -May 13, 2019
30th Jan 20197:00 amRNSOutcome of the Board Meeting held on Jan 29, 2019
2nd Nov 20187:08 amRNSOutcome of the Board Meeting- October 31, 2018
1st Aug 20187:00 amRNS1st Quarter Results
12th Jul 20187:26 amRNSThe Twenty Fourth AGM of Subex Limited
27th Jun 20187:38 amRNSSubex Limited-Outcome -Board Meeting June 26,2018
4th May 20183:00 pmRNSFinal Results
22nd Mar 201811:29 amRNSAppointment of MD & CEO of Subex Ltd
30th Jan 20189:50 amRNSFinancial Results - 3rd Quarter
13th Nov 201710:01 amRNSOutcome of Board Meeting held on November 10 2017
2nd Nov 201711:54 amRNSRestructuring of the Business wef Nov 1, 2017
5th Oct 20177:00 amRNSOutcome of Board Meeting held on October 4, 2017
22nd Aug 201711:47 amRNSOutcome of Board Meeting held on August 21, 2017
31st Jul 201711:38 amRNS1st Quarter Results
10th Jul 201711:40 amRNSRedemption of FCCB III
4th Jul 201711:05 amRNSNotice of AGM
5th Jun 201711:25 amRNSOutcome of the Board Meeting held on June 05, 2017
5th Jun 201711:15 amRNSOutcome of the Board Meeting held on June 05, 2017
26th May 20177:00 amRNSFinal Results
24th Mar 201711:41 amRNSOutcome of the Board Meeting held on March 24 2017
7th Mar 20178:26 amRNSIntimation on Redemption of FCCBs
3rd Feb 201710:46 amRNSSubex Limited 3rd Quarter Results
7th Dec 20167:50 amRNSOutcome of Board Meeting held on December 06 2016
14th Sep 20167:47 amRNS1st Quarter Results
22nd Aug 201611:14 amRNSNotice of AGM
10th Aug 201610:43 amRNSOutcome of the Board Meeting- August 9, 2016
25th May 201610:51 amRNSSubex Limited-Outcome of Board Meeting
11th Feb 201612:18 pmRNS3rd Quarter Results
3rd Nov 20152:44 pmRNSResult of Meeting
27th Aug 20158:45 amRNSSubex Limited (The Company)-Update
13th Aug 20152:00 pmRNS1st Quarter Results
3rd Jul 201511:55 amRNSNotice of the Outcome of Bondholders meeting
27th May 201512:44 pmRNSNotice of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.